Related references
Note: Only part of the references are listed.Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses
Laurent Yvan-Charvet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Evidence That Niacin Inhibits Acute Vascular Inflammation and Improves Endothelial Dysfunction Independent of Changes in Plasma Lipids
Ben J. Wu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin
Janet E. Digby et al.
ATHEROSCLEROSIS (2010)
Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice
Julien Hanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-Derived Macrophages
Christian A. Gleissner et al.
JOURNAL OF IMMUNOLOGY (2010)
The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis) Final Results and the Impact of Medication Adherence, Dose, and Treatment Duration
Todd C. Villines et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Niacin stimulates adiponectin secretion through the GPR109A receptor
Eric P. Plaisance et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Is high HDL cholesterol always good?
Anders G. Olsson
ANNALS OF MEDICINE (2009)
Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor-Deficient Mice
Frederique Dol-Gleizes et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Macrophage Diversity and Polarization in Atherosclerosis A Question of Balance
Alberto Mantovani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells
Shobha H. Ganji et al.
ATHEROSCLEROSIS (2009)
Effects of Niacin on Cell Adhesion and Early Atherogenesis: Biochemical and Functional Findings in Endothelial Cells
Subramaniam Tavintharan et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
RhoA/ROCK I signalling downstream of the P2Y(13) ADP-receptor controls HDL endocytosis in human hepatocytes
Camille Malaval et al.
CELLULAR SIGNALLING (2009)
Niacin: An Old Drug Rejuvenated
Vaijinath S. Kamanna et al.
CURRENT ATHEROSCLEROSIS REPORTS (2009)
Nicotinic acid: A new look at an old drug
John A. Farmer
CURRENT ATHEROSCLEROSIS REPORTS (2009)
Nicotinic acid and the prevention of coronary artery disease
Janet E. Digby et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
β-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice
Robert W. Walters et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
LXR and ABCA1 control cholesterol homeostasis in the proximal mouse epididymis in a cell-specific manner
Aurelia Ouvrier et al.
JOURNAL OF LIPID RESEARCH (2009)
Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function A Randomized, Placebo-Controlled, Magnetic Resonance Imaging Study
Justin M. S. Lee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Update on strategies to increase HDL quantity and function
Danielle Duffy et al.
NATURE REVIEWS CARDIOLOGY (2009)
Mechanism of action of niacin
Vaijinath S. Kamanna et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways
Fabrizio Montecucco et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Management of lipids in the prevention of cardiovascular events
Helene Glassbergi et al.
ANNUAL REVIEW OF MEDICINE (2008)
Nicotinic acid: Pharmacological effects and mechanisms of action
Andreas Gille et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and apoB-containing lipoproteins
Stefania Lamon-Fava et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice
Jose W. A. van der Hoorn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist
Hua Tang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Endothelial Cell-Specific NF-κB Inhibition Protects Mice from Atherosclerosis
Ralph Gareus et al.
CELL METABOLISM (2008)
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354):: A partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice
Graeme Semple et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Is raising HDL a futile strategy for atheroprotection?
Tisha Joy et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Spotlight on HDL-raising therapies:: insights from the torcetrapib trials
Anatol Kontush et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2008)
The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5:: Linkage to the CB2 receptor
Erinn S. Raborn et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
Christian Weber et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A)
G. Kostylina et al.
CELL DEATH AND DIFFERENTIATION (2008)
Nicotinic acid receptor agonists differentially activate downstream effectors
Jeremy G. Richman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The macrophage at the crossroads of insulin resistance and atherosclerosis
Chien-Ping Liang et al.
CIRCULATION RESEARCH (2007)
Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: An in vitro model of the niacin flush
C. Daniel Meyers et al.
ATHEROSCLEROSIS (2007)
Critical role of cholesterol ester transfer protein in nicotinic acid-mediated HDL elevation in mice
Melba Hernandez et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells
Zoltan Benyo et al.
MOLECULAR PHARMACOLOGY (2006)
Langerhans cells release prostaglandin D2 in response to nicotinic acid
Dominique Maciejewski-Lenoir et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
G12/G13 Family G proteins regulate marginal zone B cell maturation, migration, and polarization
Stefan Rieken et al.
JOURNAL OF IMMUNOLOGY (2006)
The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target
Stefan Offermanns
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
The immune response in atherosclerosis: a double-edged sword
Goran K. Hansson et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport
D Duffy et al.
CIRCULATION (2006)
Niacin induces PPARγ expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways
HJ Knowles et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis
Anatol Kontush et al.
PHARMACOLOGICAL REVIEWS (2006)
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
M. John Chapman
PHARMACOLOGY & THERAPEUTICS (2006)
Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review
LA Carlson
JOURNAL OF INTERNAL MEDICINE (2005)
Paradoxical effects of fenofibrate and nicotinic acid in apo E-deficient mice
V DeClercq et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
S Steffens et al.
NATURE (2005)
Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin
T Rubic et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells
SH Ganji et al.
JOURNAL OF LIPID RESEARCH (2004)
Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2 - A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins
AJ Taylor et al.
CIRCULATION (2004)
Niacin therapy in atherosclerosis
CD Meyers et al.
CURRENT OPINION IN LIPIDOLOGY (2004)
Molecular identification of nicotinic acid receptor
T Soga et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Molecular identification of high and low affinity receptors for nicotinic acid
A Wise et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
S Tunaru et al.
NATURE MEDICINE (2003)
Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR -: art. no. e36
MW Pfaffl et al.
NUCLEIC ACIDS RESEARCH (2002)
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
BG Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation
CA Cuff et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Sterol carrier protein-2 expression modulates protein and lipid composition of lipid droplets
BP Atshaves et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
cDNA representational difference analysis of human neutrophils stimulated by GM-CSF
S Yousefi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
